Caxton Associates »

Definium Therape shares owned by Caxton Associates

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Caxton Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $704k 37k 18.90

More positions owned by Caxton Associates

Microsoft Corporation (MSFT)
Warner Bros Discovery Com Ser A (WBD)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Amazon (AMZN)
Meta Platforms Cl A (META)
Apple (AAPL)
Boeing Company (BA)
Norfolk Southern (NSC)
Teck Resources CL B (TECK)
Electronic Arts (EA)
Penumbra (PEN)
Kenvue (KVUE)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Raytheon Technologies Corp (RTX)

View all positions for Caxton Associates

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape